Science Market Update

With 290 medical research centers and distinctive institutes, the University of California, Los Angeles is a powerhouse research university employing some of the leading life science researchers in the world. With a powerful global reputation, the University of California, Los Angeles offers a promising marketplace for lab suppliers working to market their biotech solutions and increase lab sales.

UCLA: Meet Nearly 500 Top Researchers this Fall

Perhaps you are a lab supplier with a long history of doing business with UCLA life science researchers, or maybe you are brand new to the market. Regardless of your time investment, increasing lab sales at the University of California, Los Angeles is as easy as taking advantage of Biotechnology Calendar, Inc.’s well-established connections at the university and exhibiting at the upcoming UCLA event. Why should you focus on this marketplace? Consider these most recent funding statistics for the University of California, Los Angeles:

Fred Hutchinson Cancer Research Center has a history of medical breakthroughs in cancer research, and this time, researchers at the facility are taking the lead in developing solutions to the HIV/AIDS epidemic. Thanks to enormous funding from the National Institute of Health (NIH), one powerful team of researchers from Fred Hutch in particular, along with researchers from the University of Washington and several other institutions, are running studies throughout the United States, Africa, Latin America, China, and Europe. Specifically investigating the relationship between the virus and its transmission processes, Fred Hutch researchers formed the group known as defeatHIV, in hopes of discovering whether or not the immune system can build a prevention of infection if exposed through a vaccine or otherwise.

A University of Wisconsin researcher is among one of the winners of the 2018 “Transformative Research Award,” a NIH-funded grant supporting creative scientific projects that could potentially result in a quantum leap of progress in the biosciences. A researcher from the Morgridge Institute for Research at the University of Wisconsin is one of the recipients of the award for his project, in collaboration with two other researchers, from the University of California – San Diego and the Sloan Kettering Institute. Their project was selected, along with ten other projects, to receive the award.

Launched in 2016, the Precision Medicine Initiative aims to transform our understanding of the factors that contribute to health and disease. The National Institutes of Health (NIH) provided Vanderbilt University a $31.8M grant to be used for the Precision Medicine Initiative (PMI) program with a projected project end date of December 2022. Dr. Joshua Denny, MD, MS, is a Professor of Biomedical Informatics and Medicine as well as principal investigator (PI) of the Data and Research Center of the PMI “All of Us” Research program at Vanderbilt in Nashville, Tennessee.

By Dansan4444 - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=21419527

Dr. Denny is actively collecting biological samples from volunteers and as of January 25^th, 2019 had 100,000 participants complete in-person visits. The NIH goal is to have at least one million volunteers from around the United States participate in the project in hopes of changing the “one-size-fits-all-approach” that most medical treatments are currently designed around. This large pool of data will hopefully allow medical professionals to take into account individual differences in people’s genes, environments and lifestyles to provide more personalized treatment(s). Advances in precision medicine are already transforming the way we treat diseases and various forms of cancer. New treatments are being optimized for each particular person and patients now routinely undergo molecular testing as part of patient care. The “All of Us” Research program will continue collecting data across the nation until 2022 and massive funding is being dispersed to keep the project moving forward.

• All of Us Pennsylvania (at UPitt)

• UCSD: Co Leaders, in $1.455 Billion “All of Us” Program

Vanderbilt University Funding Facts:

• 2017 Total R&D : $712,036,000
• 2017 Life Science R&D Expenditures: $542,857,000
• 2018 NIH Funding: $102,275,777

Later this fall Biotechnology Calendar looks forward to hosting its 1^st annual BioResearch Product Faire™ event at Vanderbilt where Professors, Graduate Students, Post Doctoral Candidates, Research Scientists, Grant Holders, Principal Investigators, Lab Managers and Pharmacists can network and learn about the latest science innovations. The event will take place Thursday October 3rd, 2019.

By Dansan4444 - Own work, CC0, https://commons.wikimedia.org/w/index.php?curid=15065944

If you are a lab supplier, attending the event will introduce your products and services to hundreds of researchers actively seeking the newest and latest technologies to aid their life science research.  We hope you will join us at the upcoming Vanderbilt BioResearch Product Faire™ event. 

The University of Illinois Cancer Center, the only public-university based cancer center in Chicago, is pursuing designations from the National Cancer Institute (NCI), a branch of the National Institutes of Health. The prestigious designation would mean increased financial support from the NIH, resulting in more opportunities for researchers as well as an economic benefit for the entire community.

Two Northwestern University faculty members, David Cugell and Christina Enroth-Cugell, donated a portion of their estate to the university that they loved and spent most of their lives at. The pair are known for their dedication to the students and for their inspiring work in the sciences.

Federal funding was recently provided to the University of Michigan in an effort to understand and prevent the occurrence of harmful algal blooms that fatefully impact freshwater globally. The $5.2 million federal grant supporting this algal bloom research project is part of the $1.5 billion in total annual research and development funding received by the university. 

While the major effects of these destructive algal blooms are not well understood they came under greater investigation when in 2014, the town of Toldeo, Michigan’s local water supply was contaminated as a result of an algal bloom in Lake Erie. The intention of project researchers is to increase and expand understanding of the toxins and chemical compounds associated with algal blooms and how they effect public health.

The University of Massachusetts is investigating better ways to improve risk assessments and take more effective preventative measures for breast cancer. These projects are funded by the NIH and have already been supported with more than $13.5 million. Researchers in the fields of chemical engineering, biology, veterinary and animal science, public health, health sciences, and epidemiology are all part of the effort.

The University of California at San Francisco has received, for the 12^th consecutive year, the most funding from the National Institute of Health (NIH) of all public research universities in the United States.